TickerFacts.

Company research / CVS

CVS Health Corp (CVS)

Build a valuation ↗↓ Download CSV

SEC name CVS HEALTH Corp · CIK 0000064803 · NYSE · Retail-Drug Stores and Proprietary Stores

  • Sector Retail Trade
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, CVS Health Corp reported revenue of $402.07B. Revenue grew 7.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $415.09B.

Key ratios (year ended 2025-12-31)

1.2%
Operating margin
0.4%
Net margin
2.3%
Return on year-end equity
7.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-17

Headquarters locality: Woonsocket / Rhode Island · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$415.09B$402.07B$372.81B$357.78B$322.47B$292.11B$268.71B$256.78B$194.58B$184.79B$177.55B
Cost of Revenue$230.41B$221.17B$206.29B$217.10B$196.89B$175.80B$163.98B$158.72B$156.45B$153.45B$146.53B
Gross Profit$184.68Bn/an/an/an/an/an/an/an/a$28.55B$28.86B
Operating Income$8.29B$4.66B$8.52B$13.74B$7.95B$13.31B$13.91B$11.99B$4.02B$9.54B$10.39B
Depreciation & Amortization$4.52B$4.61B$4.60B$4.37B$4.22B$4.49B$4.44B$4.37B$2.72B$2.48B$2.48B
EBITDA$12.81B$9.27B$13.11B$18.11B$12.18B$17.80B$18.35B$16.36B$6.74B$12.02B$12.86B
Net Income$4.88B$1.73B$4.59B$8.37B$4.33B$7.99B$7.19B$6.63B-$596.00M$6.62B$5.32B
EPS (Diluted)n/a$1.39$3.66$6.47$3.26$6.02$5.46$5.08-$0.57$6.44$4.90
Total Assets$253.77B$253.54B$253.22B$249.73B$228.28B$233.00B$230.72B$222.45B$196.46B$95.13B$94.46B
Total Liabilities$173.87B$178.16B$177.49B$173.09B$156.51B$157.62B$161.01B$158.28B$137.91B$57.44Bn/a
Long-Term Debtn/an/an/an/an/an/an/an/a$73.43B$27.00B$25.70B
Shareholders' Equity$79.70B$75.21B$75.56B$76.46B$71.47B$75.08B$69.39B$63.86B$58.23B$37.69B$36.83B
Cash & Equivalents$11.33B$8.45B$8.59B$8.20B$12.95B$9.41B$7.85B$5.68B$4.06B$1.70B$3.37B
Operating Cash Flow$14.78B$10.64B$9.11B$13.43B$16.18B$18.27B$15.87B$12.85B$8.87B$8.01B$10.14B
Capital Expenditures$3.02B$2.83B$2.78B$3.03B$2.73B$2.52B$2.44B$2.46B$2.04B$1.92B$2.22B
Free Cash Flow$11.76B$7.81B$6.33B$10.39B$13.45B$15.74B$13.43B$10.39B$6.83B$6.09B$7.92B
Share Repurchasesn/a$0$3.02B$2.01B$3.50B$0$0$0$0$4.36B$4.46B
Dividends Paid$3.42B$3.40B$3.37B$3.13B$2.91B$2.62B$2.62B$2.60B$2.04B$2.05B$1.84B
Shares Outstanding1.28B1.27B1.26B1.29B1.30B1.32B1.31B1.30B1.29B1.01B1.06B
Dividends Per Sharen/a$2.66$2.66$2.42$2.20$2.00$2.00$2.00$2.00$2.00$1.70
Weighted Average Diluted Sharesn/a1.27B1.26B1.29B1.32B1.33B1.31B1.30B1.04B1.02B1.08B
EPS (Basic)n/a$1.40$3.67$6.49$3.29$6.07$5.48$5.10-$0.57$6.47$4.93

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView